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Background: Worldwide, nearly 3 million people die of chronic obstructive pulmonary disease (COPD) every year. Integrated
disease management (IDM) improves disease-specific quality of life and exercise capacity for people with COPD, but can also
reduce hospital admissions and hospital days. Self-management of COPD through eHealth interventions has shown to be an
effective method to improve the quality and efficiency of IDM in several settings, but it remains unknown which factors influence
usage of eHealth and change in behavior of patients.
Objective: Our study, e-Vita COPD, compares different levels of integration of Web-based self-management platforms in IDM
in three primary care settings. The main aim of this study is to analyze the factors that successfully promote the use of a
self-management platform for COPD patients.
Methods: The e-Vita COPD study compares three different approaches to incorporating eHealth via Web-based self-management
platforms into IDM of COPD using a parallel cohort design. Three groups integrated the platforms to different levels. In groups
1 (high integration) and 2 (medium integration), randomization was performed to two levels of personal assistance for patients
(high and low assistance); in group 3 there was no integration into disease management (none integration). Every visit to the
e-Vita and Zorgdraad COPD Web platforms was tracked objectively by collecting log data (sessions and services). At the first
log-in, patients completed a baseline questionnaire. Baseline characteristics were automatically extracted from the log files
including age, gender, education level, scores on the Clinical COPD Questionnaire (CCQ), dyspnea scale (MRC), and quality of
life questionnaire (EQ5D). To predict the use of the platforms, multiple linear regression analyses for the different independent
variables were performed: integration in IDM (high, medium, none), personal assistance for the participants (high vs low),
educational level, and self-efficacy level (General Self-Efficacy Scale [GSES]). All analyses were adjusted for age and gender.
Results: Of the 702 invited COPD patients, 215 (30.6%) registered to a platform. Of the 82 patients in group 1 (high integration
IDM), 36 were in group 1A (personal assistance) and 46 in group 1B (low assistance). Of the 96 patients in group 2 (medium
integration IDM), 44 were in group 2A (telephone assistance) and 52 in group 2B (low assistance). A total of 37 patients participated
in group 3 (no integration IDM). In all, 107 users (49.8%) visited the platform at least once in the 15-month period. The mean
number of sessions differed between the three groups (group 1: mean 10.5, SD 1.3; group 2: mean 8.8, SD 1.4; group 3: mean
3.7, SD 1.8; P=.01). The mean number of sessions differed between the high-assistance and low-assistance groups in groups 1
and 2 (high: mean 11.8, SD 1.3; low: mean 6.7, SD 1.4; F1,80=6.55, P=.01). High-assistance participants used more services
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(mean 45.4, SD 6.2) than low-assistance participants (mean 21.2, SD 6.8; F1,80=6.82, P=.01). No association was found between
educational level and usage and between GSES and usage.
Conclusions: Use of a self-management platform is higher when participants receive adequate personal assistance about how
to use the platform. Blended care, where digital health and usual care are integrated, will likely lead to increased use of the online
program. Future research should provide additional insights into the preferences of different patient groups.
Trial Registration: Nederlands Trial Register NTR4098; http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=4098
(Archived by WebCite at http://www.webcitation.org/6qO1hqiJ1)
(J Med Internet Res 2017;19(5):e185)   doi:10.2196/jmir.7037
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Introduction
Chronic obstructive pulmonary disease (COPD) is a slowly
progressive lung disease and one of the main causes of morbidity
and mortality in high-, middle-, and low-income countries [1].
Worldwide, nearly 3 million people die of COPD every year;
in 2012, this was equal to approximately 6% of all deaths
globally [2,3].
According to current COPD guidelines, symptoms and airflow
obstruction should be monitored regularly to guide modification
of treatment and for early identification of complications [4,5].
Routine monitoring should contribute to achieving management
goals in COPD (ie, to delay disease progression and alleviate
its manifestations). The most important primary care objective
should be to improve quality of life (QoL) [6].
In the past decade, integrated disease management (IDM) was
introduced as a means of improving quality of care. An IDM
program for COPD consists of different components of care in
which various health care providers cooperate on education,
exercise, behavioral therapy, smoking cessation, medication,
nutrition advice, and follow-up. The responsibility for the
program lies largely with the health care professional, with a
modest role for the patient. For people with COPD, IDM not
only improves disease-specific QoL and exercise capacity, but
it can also reduce hospital admissions and hospital days per
person [7].
Self-Management of Chronic Obstructive Pulmonary
Disease
Self-management of COPD has been introduced as an effective
method to improve the quality and efficiency of IDM, and to
reduce health care costs [8-10]. Interventions to support
self-management have shown reductions in hospital admissions
and fewer sick days as a result of exacerbations [11,12]. The
core components of self-management include education, eliciting
personalized goals, psychological coping strategies, formulating
strategies to support adherence to treatment, and behavioral
change, together with practical and social support [13,14].
Chronically ill patients who have experience with
person-centered, high-quality chronic illness care that focuses
on patient activation, decision support, goal setting, problem
solving, and coordination of care are better self-managers [15].
Self-efficacy explores the emotional functioning and coping
skills of an individual and is thought to be a strong predictor of
health behavior of COPD patients; the General Self-Efficacy
Scale (GSES) tool is a reliable and sensitive measure of
self-efficacy for patients with COPD [16].
eHealth Interventions
Generally, eHealth interventions are effective in stimulating
self-management because they allow patients to better cope with
their illness at the time/place of their choosing, enabling them
to adapt their lifestyle to their condition, while reducing medical
staff consultations [17]. The deployment of eHealth apps
facilitates accessibility to health care, which enhances patients’
understanding of their disease, their sense of control, and
willingness to engage in self-management [18,19]. Although
patients’ attitudes and receptiveness toward eHealth apps are
promising in persons of a certain age and education level
[20-22], large-scale adoption of self-management and eHealth
in daily practice lags behind expectations [23].
Previous eHealth studies have revealed the challenges, barriers,
and factors that make successful implementation difficult, yet
many questions remain unanswered. Moreover, a major
challenge of eHealth in care coordination is to make it beneficial
and easy to use for health care providers and patients, otherwise
neither will use it [24]. Also, online self-management support
needs to be a fully integrated element of IDM. For example, in
a Dutch study on adherence to an online self-management app
for patients with COPD or asthma, patients tended to use the
online application on a regular basis when the health care
provider was involved, whereas patients without assistance used
the app only sporadically [25]. For barriers related to clinicians,
the eHealth evidence base needs strengthening, whereas for
primary care practices a learning process (including staff
training) needs to be instituted [26]. In addition, it is necessary
to more adequately inform patients about the possibilities and
consequences of eHealth [27]. Furthermore, poor
user-friendliness of Web-based apps and the lack of “push”
factors (eg, automated reminders or messages from health care
professionals) are a common cause of low usage or decline in
usage of Web-based apps [28]. In any eHealth study, a
substantial proportion of users drop out before completion, or
stop using the app; thus, attrition is a common problem and
should be analyzed to provide data for real-life adoption
problems [29]. Studies on the use of online self-management
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show that attrition tends to start when users “get lost” in the
intervention [28,30].
Preconditions for starting eHealth are (1) it must be well
organized within usual care (organizational perspective), (2) it
should be beneficial and easy to use for patients (human
perspective), and (3) the apps have to be technically sound
(technical perspective).
Design of e-Vita COPD
Because low usage of eHealth is an ongoing problem, we
designed a multilevel study to investigate the implementation
of a self-management Web platform to support patients with
COPD in primary care [31]. Because the Web platform provides
continuous education and contact with health care professionals,
it is expected to help patients better recognize and self-manage
exacerbations in an early phase, thereby helping to stabilize
their health status.
This study, called “e-Vita COPD,” compares three different
approaches to incorporating eHealth via Web-based
self-management platforms into the integrated disease
management of COPD using a parallel cohort design . Also,
participants are randomly allocated in two of the cohorts (1 and
2), using the same platform to different levels of personal
assistance. All three cohorts incorporated the platforms to
different levels; the two levels of personal assistance for patients
were a group with high assistance and a group with low
assistance. The main aim is to analyze the factors that
successfully promote the use of a self-management Web
platform for patients with COPD.
From an organizational perspective, our hypothesis is that a
self-management Web platform will be better adopted if the
platform is an integrated part of IDM, with trained health care
professionals who encourage patients to use the platform. From
a human perspective, our hypothesis is that a self-management
platform will be better adopted by patients if they receive
sufficient personal assistance in how to use the platform, and
will be better adopted by patients with a higher level of
self-efficacy (assessed by GSES) and a higher educational level.
From a technical perspective, our hypothesis is that a
self-management Web portal will be better adopted if the
platform is easy to use and has practical content.
Methods
Study Design
For this study, we used the CONSORT-EHEALTH checklist
that describes how the intervention should be reported [32].
We designed a quality improvement intervention and chose an
implementation study [33]. We designed a method to promote
the uptake of our research findings into routine primary health
care; with this design, we aimed at studying the influences on
health care professionals and patient behavior and at evaluating
the process by which these effects are achieved.
This research combined different study methods to investigate
organizational implementation methods and the net benefits of
eHealth interventions from a human, organizational, and
technical viewpoint. Full methodological details were reported
previously [31]. Figure 1 presents an overview of the combined
study design with organizational and technical differences.
Figure 1. Design of the e-Vita COPD Study. High, medium, and none refer to the level of integration of the web platform into the patient's integrated
disease management program. A: high assistance; B: low assistance.
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Included in the study were three different care groups (groups
1-3) and two Web portals (e-Vita and Zorgdraad). In group 1,
the online e-Vita platform was offered as a highly integrated
part of the COPD IDM with a tailor-made intensive course
program on COPD and eHealth for health care providers and
patients. Group 2 had a medium level of integration with a
standard basic course program for health care providers and
patients. The COPD patients in groups 1 and 2 who agreed to
use the platform were invited by practice nurses for intake in
which they defined a personal health goal together and discussed
how and why to use the platform. In group 3, the online platform
was offered without integration into disease management; health
care providers and patients received instructions from the Web
platform itself and received no training on COPD care.
Therefore, group 1 (high) had a high level of integration of the
Web platform into their IDM program, group 2 (medium) had
a medium level of integration into their IDM program, and group
3 (none) had no integration.
Two different levels of assistance for patients were distinguished
within group 1 (high) and 2 (medium): one with a high level of
personal assistance and one with a low level of personal
assistance. Patients in groups 1 and 2 were randomly subdivided
into two groups with high and a low levels of support.
Randomization was carried out stratified on the care group (1:1)
by computer. In group 1 (high integration-high assistance), a
high level of support consisted of two home visits to patients
by a research nurse who assisted in the use of the Web portal.
In group 2 (medium integration-high assistance), a high level
of support consisted of telephone consultation between the
patient and a research nurse who explained use of the Web
portal. In the low-assistance groups of groups 1 and 2, low-level
support consisted of a primary care nurse showing the patient
only one time how to use the Web platform, without any
follow-up instruction. Patients in group 3 that used the online
self-management platform (called “Zorgdraad”) had no active
support from health care professionals or research nurses.
Both platforms were provided for the intervention period of 15
months.
Participants
Three health care groups participated in this study. Patients were
eligible if they were diagnosed with COPD according to the
Global Initiative for Chronic Obstructive Lung Disease (GOLD)
criteria (postbronchodilator forced expiratory volume in first
second/forced vital capacity <0.7) in accordance with the COPD
Guidelines of Dutch general practitioners (GPs) [34] and they
were being treated for COPD in primary care. The study aimed
to be inclusive rather than exclusive, to achieve high external
validity (applicability to daily practice). Patients were excluded
if they were unable to fill in questionnaires, had no access to
the Internet, had a terminal illness, were immobile, or were
severe substance abusers .
Recruitment of Patients and Nonparticipation Analysis
We started by recruiting the primary care groups (groups 1-3).
Healthcare professionals decided to participate in this study
mainly because they wanted to join a project that offered
possible health care improvement. In group 1, this was 19 of
170 GPs (11%); in group 2, 29 of 34 GPs (84%); and in group
3, all 27 GPs (100%).
Patients were invited to participate by letter. When they refused
to participate, we defined them as nonparticipants. When
participants in the e-Vita study logged in and used the Web
platform at least once, we defined them as “users.” Patients
were defined as “lost to follow-up” if they did not log on to the
platform after signing informed consent and if they did not
complete the whole intervention period.
Intervention
The interventions in the three groups consisted of a
self-management program including different levels of education
for health care professionals, different levels of integration in
the COPD care program, and different levels of personal
assistance for patients. We used two Web-based platforms
(e-Vita in groups 1 and 2, Zorgdraad in group 3) that were very
similar, with the same basic features and functionalities. The
education, the care programs, and the platforms were specifically
designed for COPD patients; their needs and wishes were
processed.
The online self-management platform e-Vita is an initiative of
the Dutch foundation “Care Within Reach” [35]. The content
was created by experts guided by interviews with COPD patients
about their thoughts/feelings related to living with COPD and
its treatment; the experiences of health care professionals related
to the treatment of patients with COPD were also integrated.
The main content of the platform consists of insight into personal
health data, self-monitoring of health values, education, and a
coach for attaining personal goals. The first release of the
platform was in January 2014 with an update in May 2015
(which was during the intervention period).
All patients in groups 1 and 2 that used the e-Vita platform had
access to a telephonic and digital helpdesk to address any
problems. Patients in groups 1 and 2 that used e-Vita received
automated online reminders via email from our research team
for the self-reported questionnaires and messages.
atients in group 3 used the online self-management platform
Zorgdraad (an initiative of the Dutch foundation Zorgdraad and
the diagnostic center Saltro). The content was created by experts
guided by their experience in treating patients with COPD. The
main content of the platform is basic and consists of insight into
personal health data, self-monitoring of health values, and
education. All patients that used Zorgdraad received automated
online reminders via email for the self-reported questionnaires.
System and Services
When logging on (username plus password) for the first time
to e-Vita or Zorgdraad, every user saw a pop-up with a brief
explanation about e-Vita or Zorgdraad and the services that
could be found on the website. After the pop-up, the user was
directed to the home page. From there, users were able to access
all functionalities of the platform. The log-on procedure of both
platforms is based on Dutch security legislation and guidelines
(the Dutch Personal Data Protection Act).
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The e-Vita platform (Multimedia Appendices 1 and 2) consisted
of the following set of interrelated services, which could be
accessed via the home page:
1. An online coach for guidance when working on personal
goals and planning of the personal actions.
2. Self-monitoring personal health values and self-reported
questionnaires, in which users could register the values they
measured for the disease-specific health status Clinical
COPD Questionnaire (CCQ) [36], the modified Medical
Research Council scale (MRC scale) for dyspnea [37], the
GSES [38], sociodemographic characteristics, and EuroQol
five-dimensions questionnaire on quality of life (EQ-5D)
[39].
3. An education module with text and movies about COPD.
4. Extra information about COPD.
5. Information about the team of health care professionals
6. A module to send and receive messages to the health care
professionals.
The Zorgdraad platform (Multimedia Appendix 3) has very
basic usability and content, with the following set of interrelated
services:
1. Self-monitoring personal health values and self-reported
questionnaires, where users can register the same values as
in the e-Vita platform.
2. A basic education module with text and movies about
COPD.
3. Information about the team of health care professionals.
4. A module to send and receive messages to the health care
professionals.
Outcome Measures
Full details on outcome measures were reported previously [31].
The primary outcome of this study was the usage of the online
self-management platform: we defined usage as every visit to
e-Vita and Zorgdraad that was tracked objectively by collecting
log data in log files. We focused on the log data in the
intervention period of 15 months. The usage was divided into
sessions and services; a session was defined as the total period
between logging in and logging out of the system and a service
was defined as a focused action within the system, as described
for both platforms previously. For every action in e-Vita and
Zorgdraad (button clicks, page views, and database transactions),
the following information was collected by the Web server and
added to a log file: (1) the users’ identification number, (2) time
and day of the session, (3) the type of actions (services) taken,
and (4) optional additional information about the actions
(services). For these analyses, it was important to investigate
not only the amount of use, but also the user’s patterns.
Baseline characteristics were extracted from the log files of
e-Vita and Zorgdraad, including age, gender, education level,
and scores on the CCQ (range 0=very good health status to
6=extremely poor health status), MRC scale (range 1-5), EQ-5D,
and GSES.
Data were collected that could plausibly be related to the study
outcomes. In the analyses, the organizations of GPs (care groups
PreventZorg, Zorg op Noord, and Leidsche Rijn Julius
Gezondheidscentra), integration in IDM (integrated vs not
integrated), and personal assistance for the participants (personal
assistance vs no assistance) were used as determinants.
Education was self-reported using eight response categories and
converted into three levels based on the International Standard
Classification of Education (ISCED): high (bachelor, master,
doctor), medium (secondary and tertiary education), and low
(no formal education, primary education) [40]. Self-efficacy
was measured with the GSES in a self-reported 10-item
questionnaire. Total scores ranged from 0 to 10.
An attrition curve was drawn with the nonusage attrition; the
percentage of users who used the platforms were plotted over
time.
Statistical Methods
For the nonparticipation analysis, differences in age and gender
between participants and nonparticipants were compared using
a chi-square test and a Mann-Whitney U test after normality
tests.
Categorical baseline characteristics were reported as numbers
and percentages, normally distributed continuous variables as
means with standard deviations (SD), and nonnormally
distributed variables as medians with interquartile ranges (IQRs).
Characteristics between the three groups were explored using
chi-square tests and Kruskal-Wallis tests.
To predict the use of the e-Vita and Zorgdraad platforms,
multiple linear regression analyses (mean number of
sessions/services/mean session time/mean number of services
per session) for the different independent variables were
performed:
1. Integration in integrated disease management including
training by health care professionals by comparing groups
1 (high), 2 (medium), and 3 (none);
2. Personal assistance given to patients by comparing the
high-assistance groups of groups 1 (high) and 2 (medium)
versus the low-assistance groups of groups 1 (high) and 2
(medium);
3. Patients’ scores on the GSES; and
4. Patients’ educational levels.
We analyzed the main effects because, theoretically, we
presumed no interaction between factors. All analyses were
adjusted for age and gender.
Attrition was measured by logging and evaluating the percentage
of users that used one of the platforms every month during the
intervention period plus three months. The area under the curve
was calculated for a period of 18 months; after this period, usage
dropped to zero for two groups. We used a calculating program
to measure the area under the curve using definite integrals.
All analyses were performed with SPSS version 22.0 (IBM
Corporation, Armonk, NY, USA).
Results
In total, 942 diagnosed COPD patients from the medical files
of the three care groups were selected to be eligible for the study
(Figure 2). The GPs of these care groups excluded 240 COPD
patients from participation due to (1) other diseases, (2)
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treatment in hospital, and (3) probably incompetent to participate
in the program. In the end, 702 COPD patients were invited to
start with the e-Vita platform; of these, 215 (30.6%) agreed to
register and provided informed consent. Reasons for declining
to participate are presented in Figure 2.
Of the 215 COPD patients included at baseline, 82 were in group
1 (high), 96 in group 2 (medium), and 37 in group 3 (none).
After randomization, 36 patients in group 1 were allocated to
high-assistance group, 46 to low-assistance group; in group 2
44 patients were randomized to high-assistance group, and 52
to low-assistance group.
The total number of patients lost to follow-up was 132. Figure
2 shows the reasons for drop out in groups 1 and 2; patients in
group 3 were not asked for their reasons. Of the 215 participants,
107 (49.8%) patients were identified as platform users: 43 in
group 1, 42 in group 2, and 22 users in group 3 (Figure 3).
Figure 2. Flowchart of inclusion of participantss in the e-Vita COPD study. High, medium, and none refer to the level of integration of the web platform
into the patient's integrated disease management program. A: high assistance; B: low assistance.
Figure 3. Flowchart of the platform users of the e-Vita COPD study. High, medium, and none refer to the level of integration of the web platform into
the patient's integrated disease management program. A: high assistance; B: low assistance.
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Table 1. Characteristics and comparison of participants and nonparticipants of the e-Vita study.
TotalGroup 3 (none)Group 2 (medium)Group 1 (high)Nonparticipants/participants
Nonparticipants
727135383209n
68.5 (61.2-77.9)66.3 (60.3-74.4)69.8 (61.6-78.5)69.3 (61.1-77.5)Age (years), median (IQR)
336 (46.2)61 (46.2)167 (43.6)108 (51.7)Males, n (%)
Participantsa
215379682n
66.6 (61.4-74.7)64.1 (61.5-69.2)67.3 (62.6-76.6)66.3 (61.1-75.7)Age (years), median (IQR)
112 (52.1)20 (54.1)41 (42.7)51 (62.2)Males, n (%)
aBaseline for randomization.
Table 2. Baseline demographic and clinical characteristics of the patients with COPD included in the e-Vita study.
TotalGroup 3 (none)Group 2 (medium)Group 1 (high)Participants
LowHighLowHigh
2153752444636n
66.6 (61.4-74.7)64.1 (61.5-69.2)66.8 (60.3-75.1)68.7 (64.0-78.3)65.6 (61.3-73.4)66.3 (61.0-79.2)Age (years), (IQR)
112 (52.1)20 (54.1)24 (46.2)17 (38.6)32 (69.6)19 (52.8)Male, n (%)
Education level, n (%)
32 (36.0)7 (53.8)8 (42.1)5 (22.7)8 (38.1)4 (28.6)Low
38 (42.7)4 (30.8)8 (42.1)11 (50.0)8 (38.1)7 (50.0)Medium
19 (21.3)2 (15.8)3 (15.8)6 (27.3)5 (23.8)3 (21.4)High
Questionnaire, median (IQR)
1.2 (0.8-1.9)1.3 (0.6-1.8)1.4 (1.1-2.1)1.3 (0.9-2.1)1.2 (0.8-1.6)1.0 (0.6-1.9)CCQ
1.0 (1.0-2.0)1.0 (1.0-1.0)2.0 (1.0-2.0)2.0 (1.0-3.0)1.0 (1.0-2.0)1.0 (1.0-3.0)mMRC scale
3.3 (3.0-3.7)3.4 (3.3-3.7)3.3 (3.1-3.7)3.3 (2.8-3.5)3.3 (3.0-3.8)3.4 (3.1-3.7)GSES
0.86 (0.78-1.0)0.9 (0.84-1.0)0.84 (0.71-1.0)0.85 (0.72-1.0)0.89 (0.81-1.0)0.85 (0.7-1.0)EQ-5D
Nonparticipation Analysis
The age and gender of participants and nonparticipants are
presented in Table 1. Participants and nonparticipants did not
differ with regard to gender (52.1%, 112/215 male vs 46.2%,
336/727 male, P=.13) or age (median 66.6, IQR 61.4-74.7 vs
median 68.5, IQR 61.2-77.9 years, P=.20). Because only a few
nonparticipants filled in a questionnaire on CCQ, the mean CCQ
could not be determined for nonparticipants.
Baseline Characteristics of Patients
Table 2 presents the baseline demographic and clinical
characteristics of the included COPD population (median age
66.6 years; 52.1% was male). These patients had mildly
symptomatic COPD which is reflected by a median MRC scale
of 1.0 and a median CCQ of 1.2. Of all participants, 89 of 215
(41.4%) filled in the online questionnaire for education level;
most participants had a middle education level (42.7%). The
median GSES was 3.3 and the median EQ-5D 0.86. The
characteristics age (χ22=5.4, P=.07), education level (χ
2
4=2.2,
P=.70), GSES (χ22=1.74, P=.42), and EQ-5D (χ
2
2=2.4, P=.28)
were similar in the three groups. There was a difference in the
characteristics gender (χ22=6.8, P=.03), with more male patients
in group 1; and a difference in CCQ (χ22=6.5, P=.04) and MRC
scale (χ22=11.3, P=.003) with a higher CCQ and MRC scale in
group 2.
Use of the Online e-Vita and Zorgdraad Platforms
Table 3 presents the 15-month usage pattern by patients using
the log files of e-Vita and Zorgdraad. In total, 107 users visited
the platform at least once in the 15-month period. The helpdesk
received 101 calls; most questions concerned problems with
the log-on procedure.
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Table 3. Usage patterns for groups 1, 2, and 3.
F
2,100
PTotalGroup 3 (none)Group 2 (medium)Group 1 (high)Usagea
  107224243n
4.68.018.2 (8.7)3.7 (1.8)8.8 (1.4)10.5 (1.3)Sessions, mean (SD)
3.83.034.8 (4.3)6.7 (0.9)4.8 (0.7)3.5 (0.7)Session time (minutes), mean (SD)
7.18.00128.8 (41.0)6.7 (8.3)27.9 (6.2)45.2 (6.1)Total services per user, mean (SD)
3.97.023.6 (2.8)2.1 (0.6)4.1 (0.4)3.9 (0.4)Total services per session per user, mean (SD)
a Adjusted for age and gender.
Figure 4. Usage patterns for high and low levels of assistance. a: mean number significantly higher in high assistance group b: adjusted for age and
gender.
In the 15-month intervention period, the total number of sessions
for the e-Vita platform was 830 (9.8 per user) and for the
Zorgdraad platform 78 (3.5 per user). The mean number of
sessions differed between the three groups ((group 1: mean 10.5,
SD 1.3; group 2: mean 8.8, SD 1.4; group 3: mean 3.7, SD 1.8;
P=.01) (Table 3). In groups 2 and 3, the mean session time was
higher than in group 1; the difference between the three groups
was significant (P=.03). In groups 1 and 2, the mean number
of services in total was higher than in group 3 (group 1: mean
45.2, SD 6.1; group 2: mean 27.9, SD 6.2; group 3: mean 6.7,
SD 8.3; P=.001) and the number of services per session in
groups 1 and 2 was higher than in group 3 (group 1: mean 3.9,
SD 0.4; group 2: mean 4.1, SD 0.4; group 3: mean 2.1, SD 0.6;
P=.02).
Figure 4 shows use of the e-Vita for the two groups with high
and low assistance; higher usage of the platform was related to
a higher level of personal assistance.
The mean number of sessions differed between the
high-assistance groups and the low-assistance groups in groups
1 and 2 (high assistance: mean 11.8, SD 1.3; low assistance:
mean 6.7, SD 1.4; F1,80=6.55, P=.01). Participants in the
high-assistance groups used more services (mean 45.4, SD 6.2)
than participants in the low-assistance groups (mean 21.2, SD
6.8; F1,80=6.82, P=.01). In the high-assistance groups, the mean
number of services per session did not differ from the
low-assistance groups (mean 4.1, SD 0.4 vs mean 3.8, SD 0.5;
F1,80=0.36, P=.55).
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An overview of the online platform services visited during the
intervention period is provided in Figure 5; for every service,
the mean number per user is depicted. The log files revealed
that all services were mainly used by group 1. Furthermore, it
revealed that the e-Vita and Zorgdraad Web platforms were
predominantly used for online questionnaires, general
information, and depicting wishes/goals related to their lifestyle,
and to a lesser extent for online education, visiting the library,
and looking for information about their health care professionals.
Log files also showed that there was almost no interest in the
measurement values CCQ and MRC scale. The email feature
and an explanation of the test results of e-Vita were used to a
moderate extent.
Figure 5. Usage patterns of the mean number of services per user in each group.
Table 4. Educational level and the General Self-Efficacy Scale (GSES) as predictors for Web platform usage.
Adjusted for age and genderUnadjusted for age and genderEducation/GSES
PB (95% CI)PB (95% CI) 
.15.20Education
 –5.30 (–10.86 to 0.26) –4.40 (–9.51 to 0.71)Low 
 –1.85 (–6.61 to 2.90) –1.27 (–5.90 to 3.39)Medium 
 0.00 0.00High 
.800.67 (–4.43 to 5.78).930.23 (–4.85 to 5.31)GSES
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Figure 6. Attrition curve of group 1, 2 and 3.
Educational Level and the Generalized Self-Efficacy
Scale
The association between the educational level and scores on the
GSES and the mean number of sessions are presented in Table
4. Educational level was not associated with the number of
sessions (P=.15). No association was found between the GSES
and the mean number of sessions (P=.79).
Attrition
The log files revealed that a substantial proportion of the users
did not continuously use the platforms before completion of the
study. Figure 6 shows the patterns of use of the Web platforms
in groups 1 to 3 during the intervention period, with the
percentage of users on the y-axis, starting with 100% of the
users, and the duration of usage on the x-axis. The area under
the curve (AUC) until the 18th month for attrition in group 1
was 337.36, 254.70 in group 2, and 166.76 in group 3.
Discussion
Main Results
In this study, usage of the COPD self-management Web-based
platform is higher when the platform is an integrated part of
IDM with trained health care professionals who encourage
patients to use the platform. Furthermore, usage of the e-Vita
COPD platform is higher when patients receive more personal
assistance in learning how to use the platform. Usage of the
self-management Web-based platform e-Vita (high and medium
level of integration in IDM) is higher than that of Zorgdraad
(no integration in IDM).
Interpretation and Findings
Despite high expectations and numerous initiatives in the area
of eHealth, implementation and use of eHealth apps are not yet
common practice. Our primary aim was to analyze the factors
that successfully promote the usage of two self-management
Web platforms for COPD patients. We compared different
organizational implementation methods. An implementation
setup with greater personal support is expected to increase the
use of an online program.
Our findings highlight the importance of integrating a
Web-based platform into IDM; usage of the self-management
Web platform is higher and more varied when the platform is
an integrated part of IDM with appropriate personal coaching
for patients. Patients in care groups with a high level of
integration of the platform in IDM showed a higher number of
sessions and a larger amount of visited services with more
variation. Patients that received personal assistance also showed
higher usage of the platform. Similar results were found in a
study on COPD and asthma patients; the online app was used
on a more regular basis with higher involvement of the health
care provider and more assistance of the patients [25]. The
e-Vita study on patients with diabetes mellitus showed minimal
impact of implementing a personal health record including
self-management support in primary diabetes care;
recommendations were made to use additional strategies for
patient motivation and engagement of professionals for a
successful adoption of Web-based platforms [41,42].
In this study, we implemented extensive professional training
of health care professionals on IDM and self-management
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supported by platforms; we also offered personal assistance for
the users to guide them through the platform as well as push
factors (automated reminders or messages by health care
professionals). Both strategies are essential elements to influence
the use of platforms.
The self-efficacy of users (GSES) was not a predictor for use
of the platforms. The construct of perceived self-efficacy reflects
an optimistic self-belief [43]; a correlation can be understood
based on the belief that one can change behavior, perform a
novel or difficult task (eg, using a platform), or cope with
adversity with a higher GSES [44,45]. In a healthy Dutch
population, the mean GSES is reported to be approximately 3.1
[38,46]; in our study population, the median GSES was 3.3.
Educational level was not a predictor of use of the e-Vita COPD
platform. These predictors might be useful for future studies on
and the development of platforms.
The EQ-5D values reflect the relative desirability of health states
on a scale in which 1 refers to full health and 0 refers to death.
In our study population, the median EQ-5D was 0.86 compared
with 0.87 in a healthy Dutch population [47].
In the three groups, there was no bias regarding baseline age,
gender, education level, CCQ, MRC scale, GSES, and EQ-5D.
Analysis of attrition provided insight into the decrease in usage
(eg, after 1 month, 10%-45% of the participants were actively
using the platform). The periodic steep rise in the percentage
of users might be explained by the email reminders sent by the
platform to fill in the questionnaires; all users received
continuous reminders during the intervention period. In group
3, all users received urgent and repeated requests to fill in
questionnaires at the end of the intervention period, which
probably explains the steep rise in the percentage of users at the
end of the study. The attrition curve depicts the “push factors”
that are required to remind participants to use the platform. This
“law of attrition” (the phenomenon of participants stopping
usage) is a common finding in eHealth evaluations and one of
the fundamental and methodological challenges in the evaluation
of eHealth apps [29].
During this study, there were several lessons learned by the
research team. First, it took a lot of effort to motivate health
care professionals to work together with patients on
self-management platforms; we experienced differences in
communication skills among the health care professionals
working with patients in a more modern, less hierarchic way.
When patients started using the platform, it took great effort to
stimulate the usage with several reminders, even though we
established a high amount of attrition probably due to low
usability of the platforms and logging problems.
Strengths and Limitations
This e-Vita COPD study has several strengths. To our
knowledge, it is the first to combine different study designs
thereby enabling simultaneous investigation of clinical effects,
as well as the effects of different organizational implementation
methods. Randomization was carried out for the level of
assistance for patients. This study also adds evidence to the
existing body of knowledge; this is important because local
political and financial factors have a major impact on successful
integration of eHealth in daily practice [48].
This study also has limitations. Although well-conducted
randomized trials provide the most reliable evidence on the
effectiveness of interventions, they are not feasible for our
setting of an implementation design with organizational changes
in a real-life health care system within three different care groups
with different demands.
From a technical perspective, development of the Web-based
platforms was difficult due to a lack of broad experience in the
field. We used two different platforms with the same basic
principles and functionalities. The platforms were new and the
usability was not tested thoroughly before starting the study.
The platform technique and the decisions made during the design
phase were beyond the influence of our research group, but have
affected our outcomes. From a human perspective,
self-management skills imply behavioral changes. Behavioral
changes require time, whereas the study period was restricted
to 15 months. Furthermore, patients in a primary care setting
have a low burden of disease (in this study, the mean CCQ score
was 1.2) and motivation to use the platform might be negatively
influenced by this fact. In respiratory medicine, there is a lack
of research on patients with mild to moderate COPD despite
that more than 80% of COPD patients suffer from this stage of
disease and are often treated in primary care [49]. From an
organizational perspective, other projects in primary care
cooperatives can influence the speed and thoroughness of the
implementation of our Web portal. Finally, this study also has
typical limitations found in eHealth trials. The loss to follow-up
is high, as in all eHealth studies. Because general practices, as
well as patients, were free to volunteer, bias might have occurred
in our research groups. Users were self-selected and were
presumably motivated to use the Web-based platform as would
be expected in a real-life setting. The patients that were invited
by GPs/nurses to participate in the study might differ from other
patient groups. Furthermore, GPs excluded 26% of the COPD
patients from this study. Of the 702 eligible patients, 215
(30.6%) were willing to participate and provided informed
consent, and 132 (61.4%) of the participants dropped out during
follow-up. Even though nonparticipants did not differ in age
and gender from participants, caution is required when
generalizing these results to general practice as a whole.
However, the practical applicability of our results for other
primary care groups is positive (ie, the study provides practical
insight into successful implementation of patient platforms).
Nevertheless, primary care organizations should take into
account the different aspects of good organization of blended
care and good quality of implementation.
More studies are needed (preferably with larger sample groups
and among the nonusers) to gain more insight into the
preferences of various patient groups. The substantial workload
generated by integrating a Web-based platform in IDM
emphasizes the importance of piloting and assessing workforce
implications for primary care groups during the planning and
implementation phase. These results provide additional insight
into the organizational aspects of the implementation of
platforms, including the need to assist patients in the use of
Web-based platforms integrated in IDM.
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Use of a self-management Web-based platform is higher when
the platform is an integrated part of IDM, with trained health
care professionals encouraging patients to use the platform.
Use of a self-management platform is higher when participants
receive adequate personal assistance about how to use the
platform.
The self-management Web-based platform e-Vita had higher
usage than Zorgdraad, which is probably due to the superior
organizational conditions of integrated care and because e-Vita
is, technically, better customized for use. An implementation
setup with blended care through integration of the online
platform in IDM, together with greater personal support of the
users, will likely lead to increased use of the online program.
Future research should provide additional insights into the
preferences of different patient groups.
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